THOMEER, Michiel

Email Alert RSS Feed

Profile

Full Name
THOMEER, Michiel
Email
michiel.thomeer@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]

Results 41-58 of 58 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
412013Metabolic phenotyping of blood plasma by 1H-NMR spectroscopy to detect lung cancer?LOUIS, Evelyne; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; Vandeurzen, K.; Sadowska, A.; REEKMANS, Gunter; ADRIAENSENS, PeterConference MaterialC2
422013Metabolic phenotyping by 1H-NMR spectroscopy detects lung cancer via a simple blood sampleLOUIS, Evelyne; MESOTTEN, Liesbet; THOMEER, Michiel; Vandeurzen, Kurt; Darquennes, Karen; VANHOVE, Karolien; REEKMANS, Gunter; ADRIAENSENS, PeterConference MaterialC2
432013Evaluation of 1H-NMR spectroscopy in predicting platine-related toxicities in lung cancer patients.VANHOVE, Karolien; LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; ADRIAENSENS, PeterConference MaterialC2
442013Methotrexate vs Azathioprine in Second-line Therapy of SarcoidosisVorselaars, Adriane D. M.; Wuyts, Wim A.; Vorselaars, Veronique M. M.; Zanen, Pieter; Deneer, Vera H. M.; Veltkamp, Marcel; THOMEER, Michiel; van Moorsel, Coline H. M.; Grutters, Jan C.Journal ContributionA1
452012Bepalen van het metabool fenotype bij longkanker: klinisch toepasbaar of irrelevant?LOUIS, Evelyne; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, PeterConference MaterialC2
462012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VAN DER SPEETEN, Kurt; GUEDENS, Wanda; ADRIAENSENS, PeterConference MaterialC2
472012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
482012New Idiopathic Pulmonary Fibrosis Guidelines: Some Unresolved Questionswuyts, W.A.; THOMEER, Michiel; Demeths, M.G.; Verleden, G.M.Journal ContributionA1
492012Treatment strategies for sarcoidosisViaene, E.; THOMEER, Michiel; Slabbynck, H; Wuyts, WJournal ContributionA1
502012METABOLIC PHENOTYPE BY NMR SPECTROSCOPY: A BIOMARKER FOR LUNG CANCERLOUIS, Evelyne; REEKMANS, Gunter; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; MEBIS, Jeroen; Vandeurzen, Kurt; Darquennes, Karen; ADRIAENSENS, PeterConference MaterialC2
512011Newer modes of treating interstitial lung diseaseWuyts, Wim A.; THOMEER, Michiel; Demedts, Maurits G.Journal ContributionA1
522011Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important differencedu Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Kartashov, Alex; King, Talmadge E.; Lancaster, Lisa; Noble, Paul W.; Sahn, Steven A.; THOMEER, Michiel; Valeyre, Dominique; Wells, Athol U.Journal ContributionA1
532011Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of Ga-67 imaging and F-18-FDG PETKeijsers, R.G.; Grutters, J.C.; THOMEER, Michiel; Du Bois, R.M.; Van Buul, M.M.; Lavalaye, J.; Van Den Bosch, J.M.; Verzijlbergen, F.J.Journal ContributionA2
542011Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosisdu Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z; Costabel, Ulrich; Kartashov, Alex; Lancaster, Lisa; Noble, Paul W.; Raghu, Ganesh; Sahn, Steven A.; Szwarcberg, Javier; THOMEER, Michiel; Valeyre, Dominique; King, Talmadge E.Journal ContributionA1
552011Metabolic phenotyping by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
562011Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis Test Validation and Minimal Clinically Important Differencedu Bois, RM; Weycker, D; Albera, C; Bradford, WZ; Costabel, U; Kartashov, A; Lancaster, L; Noble, PW; Sahn, SA; Szwarcberg, J; THOMEER, Michiel; Valeyre, D; King, TEJournal ContributionA1
572010Azithromycin reduces pulmonary fibrosis in a bleomycin mouse modelWuyts, W.A.; Willems, S.; Vos, R.; Vanaudenaerde, B.M.; De Vleeschauwer, S.I.; Rinaldi, M.; Vanhooren, H.M.; Geudens, N.; Verleden, S.E.; Demedts, M.G.; THOMEER, Michiel; Verbeken, E.K.; Verleden, G.M.Journal ContributionA1
582010Clinical use of biomarkers of survival in pulmonary fibrosisTHOMEER, Michiel; Grutters, Jan; Wuyts, Wim; Willems, Stijn; Demedts, MauritsJournal ContributionA1
show all